Cargando…
Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
Tumor necrosis factor receptor‐associated factor 4 (TRAF4) is overexpressed in a variety of carcinomas of different origins, but its role in tumorigenesis remains incompletely understood. Previous studies suggest that TRAF4 promotes epidermal growth factor receptor (EGFR) activation in non‐small cel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527583/ https://www.ncbi.nlm.nih.gov/pubmed/35748027 http://dx.doi.org/10.1002/2211-5463.13458 |
_version_ | 1784801107808092160 |
---|---|
author | He, Siwei Dong, Danfeng Lin, Jiafei Wu, Beiying Nie, Xiaomeng Cai, Gang |
author_facet | He, Siwei Dong, Danfeng Lin, Jiafei Wu, Beiying Nie, Xiaomeng Cai, Gang |
author_sort | He, Siwei |
collection | PubMed |
description | Tumor necrosis factor receptor‐associated factor 4 (TRAF4) is overexpressed in a variety of carcinomas of different origins, but its role in tumorigenesis remains incompletely understood. Previous studies suggest that TRAF4 promotes epidermal growth factor receptor (EGFR) activation in non‐small cell lung cancer (NSCLC). However, the downstream signaling pathway of TRAF4‐mediated EGFR activation, as well as its effects on tumor cells, have not been fully elucidated. Here we report that TRAF4 overexpression is associated with increased activity of extracellular signal‐regulated kinase 5 (ERK5) in NSCLC tissues. Activation of ERK5 was dependent on TRAF4‐mediated EGFR activation, since inhibition of either TRAF4 or EGFR dramatically abolished phosphorylation of ERK5. Mechanistically, EGFR recruited mitogen‐activated protein kinase kinase kinase 3 (MEKK3), an upstream kinase of ERK5, in a TRAF4‐dependent manner. Thus, our data suggest that an EGFR‐TRAF4‐MEKK3‐ERK5 axis promotes the proliferation of tumor cells, and this may be a potential target for therapeutic intervention of NSCLC. |
format | Online Article Text |
id | pubmed-9527583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95275832022-10-06 Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5 He, Siwei Dong, Danfeng Lin, Jiafei Wu, Beiying Nie, Xiaomeng Cai, Gang FEBS Open Bio Research Articles Tumor necrosis factor receptor‐associated factor 4 (TRAF4) is overexpressed in a variety of carcinomas of different origins, but its role in tumorigenesis remains incompletely understood. Previous studies suggest that TRAF4 promotes epidermal growth factor receptor (EGFR) activation in non‐small cell lung cancer (NSCLC). However, the downstream signaling pathway of TRAF4‐mediated EGFR activation, as well as its effects on tumor cells, have not been fully elucidated. Here we report that TRAF4 overexpression is associated with increased activity of extracellular signal‐regulated kinase 5 (ERK5) in NSCLC tissues. Activation of ERK5 was dependent on TRAF4‐mediated EGFR activation, since inhibition of either TRAF4 or EGFR dramatically abolished phosphorylation of ERK5. Mechanistically, EGFR recruited mitogen‐activated protein kinase kinase kinase 3 (MEKK3), an upstream kinase of ERK5, in a TRAF4‐dependent manner. Thus, our data suggest that an EGFR‐TRAF4‐MEKK3‐ERK5 axis promotes the proliferation of tumor cells, and this may be a potential target for therapeutic intervention of NSCLC. John Wiley and Sons Inc. 2022-08-17 /pmc/articles/PMC9527583/ /pubmed/35748027 http://dx.doi.org/10.1002/2211-5463.13458 Text en © 2022 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles He, Siwei Dong, Danfeng Lin, Jiafei Wu, Beiying Nie, Xiaomeng Cai, Gang Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5 |
title | Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
|
title_full | Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
|
title_fullStr | Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
|
title_full_unstemmed | Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
|
title_short | Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
|
title_sort | overexpression of traf4 promotes lung cancer growth and egfr‐dependent phosphorylation of erk5 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527583/ https://www.ncbi.nlm.nih.gov/pubmed/35748027 http://dx.doi.org/10.1002/2211-5463.13458 |
work_keys_str_mv | AT hesiwei overexpressionoftraf4promoteslungcancergrowthandegfrdependentphosphorylationoferk5 AT dongdanfeng overexpressionoftraf4promoteslungcancergrowthandegfrdependentphosphorylationoferk5 AT linjiafei overexpressionoftraf4promoteslungcancergrowthandegfrdependentphosphorylationoferk5 AT wubeiying overexpressionoftraf4promoteslungcancergrowthandegfrdependentphosphorylationoferk5 AT niexiaomeng overexpressionoftraf4promoteslungcancergrowthandegfrdependentphosphorylationoferk5 AT caigang overexpressionoftraf4promoteslungcancergrowthandegfrdependentphosphorylationoferk5 |